Multiple sclerosis: First drug to help patients walk now on NHS in England
Thousands of multiple sclerosis patients in England gain NHS access to fampridine, the first medication approved to improve walking ability.
3 independently checked trend briefs about this subject, newest first.
headlinez.news detected 3 source-qualified news clusters connected to Mhra between June 23, 2026 and July 23, 2026. They span 1 newsroom category and average 8.7 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
Thousands of multiple sclerosis patients in England gain NHS access to fampridine, the first medication approved to improve walking ability.
Medical professionals are issuing warnings regarding how common medications can increase heat-related health risks during high-temperature events.
The MHRA has issued a new safety update regarding the risk of angioedema associated with the use of ACE inhibitor blood pressure medications.